Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) Shares Outstanding (Weighted Average): 2010-2025

Historic Shares Outstanding (Weighted Average) for Geron (GERN) over the last 16 years, with Sep 2025 value amounting to $638.0 million.

  • Geron's Shares Outstanding (Weighted Average) rose 5.84% to $638.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $638.0 million, marking a year-over-year increase of 5.84%. This contributed to the annual value of $604.5 million for FY2024, which is 11.31% up from last year.
  • According to the latest figures from Q3 2025, Geron's Shares Outstanding (Weighted Average) is $638.0 million, which was up 0.17% from $636.9 million recorded in Q2 2025.
  • Geron's 5-year Shares Outstanding (Weighted Average) high stood at $638.0 million for Q3 2025, and its period low was $318.5 million during Q1 2021.
  • For the 3-year period, Geron's Shares Outstanding (Weighted Average) averaged around $576.6 million, with its median value being $593.1 million (2024).
  • Data for Geron's Shares Outstanding (Weighted Average) shows a peak YoY soared of 58.99% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Geron's Shares Outstanding (Weighted Average) stood at $321.9 million in 2021, then grew by 18.41% to $381.2 million in 2022, then skyrocketed by 42.45% to $543.1 million in 2023, then grew by 11.31% to $604.5 million in 2024, then climbed by 5.84% to $638.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $638.0 million for Q3 2025, versus $636.9 million for Q2 2025 and $636.9 million for Q1 2025.